Understanding how and when Peyronie’s disease stabilization can occur over time helps guide clinical diagnosis, follow-up, and the evaluation of treatment options suited to each case.
Noticing changes such as penile curvature, apparent loss of length, or narrowing of the penis over time can be a worrying experience. In many cases, the inflammatory phase tends to stabilize, although anatomical changes may persist and should be assessed by a urologist.
Peyronie’s disease stabilization is an important stage for clinical assessment, as it helps evaluate penile curvature, penile function, and the impact of the condition on the patient’s sexual life.
This stage also makes it possible to assess, on an individual basis, whether there is an indication for surgical treatment, with the aim of improving sexual function and addressing anatomical or functional changes that interfere with sexual intercourse.
Clinical introduction to Peyronie’s disease
Peyronie’s disease is characterized by the formation of fibrosis inside the penis, in a membrane called the tunica albuginea. These plaques cause the penis to change its anatomy due to a loss of tissue elasticity.
As a result, the side affected by fibrosis may develop curvature during erection, since expansion of the corpora cavernosa becomes limited. Penile length may also be affected, and narrowing may occur in some cases.
This process occurs in two phases: the acute phase and the chronic phase.
- Acute or inflammatory phase: the areas of fibrosis are still evolving, meaning that curvature may progress over time.
- Chronic phase: the fibrosis is clinically stable, with no evidence of recent curvature progression.
Therefore, understanding which phase the patient is in is important for guiding clinical follow-up and choosing the most appropriate treatment options.
Men in the initial phase often require only monitoring by a urologist. In addition, if erectile dysfunction is present, medical treatment may be started.
When the fibrosis enters the chronic phase, it is time to assess the degree of curvature and penile functionality. If sexual life is compromised, surgery for Peyronie’s disease may be recommended.
Acute phase and Peyronie’s disease stabilization
The acute phase corresponds to the period from symptom onset until Peyronie’s disease stabilization.
At this stage, the tunica albuginea presents usually recent micro-injuries that are inflamed and will give rise to the fibrous plaque.
Clinical characteristics
This phase is marked by dynamic fibrous plaque formation, with the following noticeable symptoms during erection:
- Pain associated with the inflammatory process;
- Progression of penile curvature;
- Erectile dysfunction, in some cases;
- A feeling that the penis “slips out” during sexual intercourse, in some cases.
Typical duration
The chronological progression of Peyronie’s disease may vary, and stabilization often occurs between 6 and 18 months after symptom onset, depending on each individual’s biological response.
Penile fibrosis must meet certain stability criteria to be considered clinically stable.
When Peyronie’s disease stabilizes, the fibrosis tends to stop showing signs of inflammatory activity and structural progression, and there may be a significant reduction or absence of pain during erection.
Transition to the chronic phase: Peyronie’s disease stabilization
The chronic phase of Peyronie’s disease should be confirmed by a urologist in order to safely consider treatment options for the patient.
Clinical definition of stabilization
Clinical stabilization of Peyronie’s disease is defined by the absence of relevant changes in penile curvature and in the characteristics of the fibrous plaque over time, with no signs of recent structural progression. In other words, the active inflammatory process is considered to have resolved.
In the chronic phase of Peyronie’s disease, the previously stabilized plaque tends not to worsen. However, in some cases, other areas of the penis may develop new fibrotic changes.
Signs that the disease is stable
The following clinical criteria may be considered signs of stable penile curvature and resolution of inflammation in the tunica albuginea:
- Substantial reduction or absence of pain during erection;
- Absence of relevant curvature progression;
- Fibrous plaque without recent changes, maintaining similar characteristics on palpation and penile ultrasound assessment.
The consistent presence of these signs over several months reinforces the diagnosis of Peyronie’s disease stabilization.
Importance of medical follow-up
Urological clinical follow-up is important for evaluating Peyronie’s disease stabilization.
The urologist can document anatomical and functional changes, as well as the presence or absence of pain reported by the patient, to assess whether the condition has reached a stable phase.
In addition, during consultation, the patient may undergo complementary tests, such as penile ultrasound, which may be important for assessing the characteristics of fibrosis, including location, extent, and severity.
Treatment implications of Peyronie’s disease stabilization
Peyronie’s disease stabilization is a relevant factor when evaluating the possible need for, and indication of, surgical treatment for penile curvature.
Conservative treatment vs intervention
The therapeutic approach to Peyronie’s disease depends directly on the stage of disease progression.
While inflammation of the tunica albuginea persists, definitive correction of penile curvature may not be indicated, and management should be defined according to an individualized clinical assessment.
Treatments indicated for the initial phase of Peyronie’s disease aim to reduce inflammatory activity, monitor curvature progression, and preserve the patient’s sexual function whenever possible.
The combination of colchicine and vitamin E may, in some cases, be considered with the aim of acting on inflammation of the tunica albuginea. This approach should be evaluated by the physician, taking into account the disease phase, symptoms, and curvature progression.
Men who already present mild or moderate erectile dysfunction during the acute phase may have an indication for treatment with sildenafil or tadalafil after medical evaluation. These medications may help improve erection quality and, in some cases, facilitate penetration.
Once Peyronie’s disease stability is confirmed, the possible need for surgical treatment may be assessed according to the symptoms, curvature, and functional impact in each patient.
If the curvature stabilizes at an angle that does not compromise the patient’s sexual life, surgery may not be necessary.
Very pronounced curvatures may be associated with erectile dysfunction. In selected cases, surgery may aim to correct deformities, improve penile functionality, and, when indicated, allow placement of a penile implant to support the rigidity required for sexual intercourse.
Criteria for considering surgical intervention
Surgery for Peyronie’s disease may be considered when the patient presents significant penile deformity, with or without associated erectile dysfunction, provided there is relevant functional impact and clinical indication after specialist assessment.
In some cases, the curvature may reach angles close to 90°, making sexual activity difficult or impossible, even in the absence of erectile dysfunction.
In other cases, there may be more than one point of fibrosis, causing deformities in different segments of the penis, which may also compromise penetration.
On the other hand, even mild curvatures may be associated with relevant erectile dysfunction, and reconstructive surgery with penile implant placement may be considered in selected cases.
It is important to speak with the doctor to understand the individual clinical condition, the potential benefits, limitations, and risks of the surgical procedure, so that expectations can be aligned realistically.
Information and follow-up during Peyronie’s disease stabilization
The stable phase of Peyronie’s disease is an important stage in the clinical follow-up of men living with this condition. Throughout this process, it is important that they receive appropriate and individualized medical guidance.
Clinical follow-up and individualized medical assessment are important because each clinical case should be analyzed according to its symptoms, progression, and functional impact. Timely evaluation may contribute to more appropriate therapeutic guidance.
To receive guidance on Peyronie’s disease and understand which options may be appropriate for your case, seek specialized medical assessment.